id todo:paper_00137227_v153_n8_p3747_Liu
record_format dspace
spelling todo:paper_00137227_v153_n8_p3747_Liu2023-10-03T14:11:23Z Progesterone receptors: A key for neuroprotection in experimental stroke Liu, A. Margaill, I. Zhang, S. Labombarda, F. Coqueran, B. Delespierre, B. Liere, P. Marchand-Leroux, C. O'Malley, B.W. Lydon, J.P. De Nicola, A.F. Sitruk-Ware, R. Mattern, C. Plotkine, M. Schumacher, M. Guennoun, R. 3alpha hydroxy 5alpha pregnan 20 one 4 aminobutyric acid 5alpha pregnane 3,20 dione elcometrine progesterone progesterone receptor animal experiment animal model animal tissue article controlled study disease predisposition gene inactivation haploinsufficiency hypoxic ischemic encephalopathy middle cerebral artery occlusion motor dysfunction mouse neuroprotection nonhuman priority journal signal transduction stroke Animals Brain Male Mice Mice, Knockout Norprogesterones Pregnanolone Progesterone Receptors, Progesterone Signal Transduction Stroke Progesterone receptors (PR) are expressed throughout the brain. However, their functional significance remains understudied. Here we report a novel role of PR as crucial mediators of neuroprotection using a model of transient middle cerebral artery occlusion and PR knockout mice. Six hours after ischemia, we observed a rapid increase in progesterone and 5α-dihydroprogesterone, the endogenous PR ligands, a process that may be a part of the natural neuroprotective mechanisms. PR deficiency, and even haploinsufficiency, increases the susceptibility of the brain to stroke damage. Within a time window of 24 h, PR-dependent signaling of endogenous brain progesterone limits the extent of tissue damage and the impairment of motor functions. Longer-term improvement requires additional treatment with exogenous progesterone and is also PR dependent. The potent and selective PR agonist Nestorone is also effective. In contrast to progesterone, levels of the neurosteroid allopregnanolone, which modulates γ-aminobutyric acid type A receptors, did not increase after stroke, but its administration protected both wild-type and PR-deficient mice against ischemic damage. These results show that 1) PR are linked to signaling pathways that influence susceptibility to stroke, and 2) PR are direct key targets for both endogenous neuroprotection and for therapeutic strategies after stroke, and they suggest a novel indication for synthetic progestins already validated for contraception. Although allopregnanolone may not be an endogenous neuroprotective agent, its administration protects the brain against ischemicdamageby signaling mechanisms not involving PR. Collectively, our data clarify the relative roles of PR and allopregnanolone in neuroprotection after stroke. Copyright © 2012 by The Endocrine Society. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00137227_v153_n8_p3747_Liu
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 3alpha hydroxy 5alpha pregnan 20 one
4 aminobutyric acid
5alpha pregnane 3,20 dione
elcometrine
progesterone
progesterone receptor
animal experiment
animal model
animal tissue
article
controlled study
disease predisposition
gene inactivation
haploinsufficiency
hypoxic ischemic encephalopathy
middle cerebral artery occlusion
motor dysfunction
mouse
neuroprotection
nonhuman
priority journal
signal transduction
stroke
Animals
Brain
Male
Mice
Mice, Knockout
Norprogesterones
Pregnanolone
Progesterone
Receptors, Progesterone
Signal Transduction
Stroke
spellingShingle 3alpha hydroxy 5alpha pregnan 20 one
4 aminobutyric acid
5alpha pregnane 3,20 dione
elcometrine
progesterone
progesterone receptor
animal experiment
animal model
animal tissue
article
controlled study
disease predisposition
gene inactivation
haploinsufficiency
hypoxic ischemic encephalopathy
middle cerebral artery occlusion
motor dysfunction
mouse
neuroprotection
nonhuman
priority journal
signal transduction
stroke
Animals
Brain
Male
Mice
Mice, Knockout
Norprogesterones
Pregnanolone
Progesterone
Receptors, Progesterone
Signal Transduction
Stroke
Liu, A.
Margaill, I.
Zhang, S.
Labombarda, F.
Coqueran, B.
Delespierre, B.
Liere, P.
Marchand-Leroux, C.
O'Malley, B.W.
Lydon, J.P.
De Nicola, A.F.
Sitruk-Ware, R.
Mattern, C.
Plotkine, M.
Schumacher, M.
Guennoun, R.
Progesterone receptors: A key for neuroprotection in experimental stroke
topic_facet 3alpha hydroxy 5alpha pregnan 20 one
4 aminobutyric acid
5alpha pregnane 3,20 dione
elcometrine
progesterone
progesterone receptor
animal experiment
animal model
animal tissue
article
controlled study
disease predisposition
gene inactivation
haploinsufficiency
hypoxic ischemic encephalopathy
middle cerebral artery occlusion
motor dysfunction
mouse
neuroprotection
nonhuman
priority journal
signal transduction
stroke
Animals
Brain
Male
Mice
Mice, Knockout
Norprogesterones
Pregnanolone
Progesterone
Receptors, Progesterone
Signal Transduction
Stroke
description Progesterone receptors (PR) are expressed throughout the brain. However, their functional significance remains understudied. Here we report a novel role of PR as crucial mediators of neuroprotection using a model of transient middle cerebral artery occlusion and PR knockout mice. Six hours after ischemia, we observed a rapid increase in progesterone and 5α-dihydroprogesterone, the endogenous PR ligands, a process that may be a part of the natural neuroprotective mechanisms. PR deficiency, and even haploinsufficiency, increases the susceptibility of the brain to stroke damage. Within a time window of 24 h, PR-dependent signaling of endogenous brain progesterone limits the extent of tissue damage and the impairment of motor functions. Longer-term improvement requires additional treatment with exogenous progesterone and is also PR dependent. The potent and selective PR agonist Nestorone is also effective. In contrast to progesterone, levels of the neurosteroid allopregnanolone, which modulates γ-aminobutyric acid type A receptors, did not increase after stroke, but its administration protected both wild-type and PR-deficient mice against ischemic damage. These results show that 1) PR are linked to signaling pathways that influence susceptibility to stroke, and 2) PR are direct key targets for both endogenous neuroprotection and for therapeutic strategies after stroke, and they suggest a novel indication for synthetic progestins already validated for contraception. Although allopregnanolone may not be an endogenous neuroprotective agent, its administration protects the brain against ischemicdamageby signaling mechanisms not involving PR. Collectively, our data clarify the relative roles of PR and allopregnanolone in neuroprotection after stroke. Copyright © 2012 by The Endocrine Society.
format JOUR
author Liu, A.
Margaill, I.
Zhang, S.
Labombarda, F.
Coqueran, B.
Delespierre, B.
Liere, P.
Marchand-Leroux, C.
O'Malley, B.W.
Lydon, J.P.
De Nicola, A.F.
Sitruk-Ware, R.
Mattern, C.
Plotkine, M.
Schumacher, M.
Guennoun, R.
author_facet Liu, A.
Margaill, I.
Zhang, S.
Labombarda, F.
Coqueran, B.
Delespierre, B.
Liere, P.
Marchand-Leroux, C.
O'Malley, B.W.
Lydon, J.P.
De Nicola, A.F.
Sitruk-Ware, R.
Mattern, C.
Plotkine, M.
Schumacher, M.
Guennoun, R.
author_sort Liu, A.
title Progesterone receptors: A key for neuroprotection in experimental stroke
title_short Progesterone receptors: A key for neuroprotection in experimental stroke
title_full Progesterone receptors: A key for neuroprotection in experimental stroke
title_fullStr Progesterone receptors: A key for neuroprotection in experimental stroke
title_full_unstemmed Progesterone receptors: A key for neuroprotection in experimental stroke
title_sort progesterone receptors: a key for neuroprotection in experimental stroke
url http://hdl.handle.net/20.500.12110/paper_00137227_v153_n8_p3747_Liu
work_keys_str_mv AT liua progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT margailli progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT zhangs progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT labombardaf progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT coqueranb progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT delespierreb progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT lierep progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT marchandlerouxc progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT omalleybw progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT lydonjp progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT denicolaaf progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT sitrukwarer progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT matternc progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT plotkinem progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT schumacherm progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
AT guennounr progesteronereceptorsakeyforneuroprotectioninexperimentalstroke
_version_ 1807323042951462912